Digital health company Ro is adding reproductive health to its growing platform with plans to acquire Modern Fertility. The deal, announced Wednesday, is valued north of $225 million, according to ...

Jan 13 (Reuters) - U.S. telehealth firm Ro said on Tuesday it has entered a research collaboration with drugmaker Amgen to ...

Ro, formerly known as Roman, offers telehealth services for hair loss, erectile dysfunction, fertility, and weight loss. The company provides discreet packaging and fast shipping. Ro Body is the brand ...

You may know of Ro hair loss as “Roman,” the initial name of the digital and goal-oriented healthcare brand. What started as a one-stop shop for at-home erectile dysfunction (ED) meds like generic ...

Gifthealth will dispense the vials to patients who receive Zepbound prescriptions through a provider affiliated with Ro. Zepbound vials are a cash-pay product offered only through LillyDirect, meaning ...

Ro — formerly called Roman — is a telehealth company offering services for individuals with a number of common health concerns, including erectile dysfunction (ED), fertility, hair loss, weight loss, ...

At a time when telehealth services are in high-demand because of the coronavirus pandemic, telehealth startup Ro said Monday that it is valued at $1.5 billion after closing a $200 million Series C led ...

Ro's Body Program is a comprehensive weight loss solution that offers personalized plans utilizing a glucagon-like peptide-1 (GLP-1) receptor agonist medications such as Ozempic, Wegovy and Zepbound.

Ro, a digital elective care and telemedicine provider last valued at $5 billion, announced today that it has acquired Modern Fertility, a reproductive health company founded in 2017. Axios estimates ...